evidencegaps
Primary study · included by 1 review

Pilot experience of [161Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry.

Rosar 2025 · Rosar Florian, Burgard Caroline, Petrescu Christine, et al. · Theranostics · 2025

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.
Non-Cochrane · intervention · 2026 · cited as Rosar 2025 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.